Biogen and Alectos Team Up to Advance AL01811 for Parkinson’s

[PDWarrior1900]

"Biogen and Alectos Therapeutics have signed an exclusive license and collaboration agreement to further develop and commercialize AL01811, a small molecule therapy, as a potential treatment for Parkinson’s disease."

“Through this collaboration with Alectos, we hope to improve the lives of people living with Parkinson’s disease by advancing the research and development of a potential-first-in-class oral treatment that may slow disease progression,” Priya Singhal, MD, interim head of research and development at Biogen, said in a press release. “At Biogen, we aim to advance therapies that serve people with movement disorders, enabling them to have greater independence and quality of life.”

parkinsonsnewstoday.com/202...

--------------------------------------------------------------------------

STAY STRONG!

A 'MIRACLE CURE' for everyone is just around the corner!

[WinnieThePoo]

It's good to know that there are ever more options to improve Parkinson’s being developed. Folk diagnosed in 10 years time are going to have a very different disease experience from us. But this is at a pre-clinical phase. It's going to be a while before we get it prescribed